GLP-1 weight loss medication shortages have been widespread since 2023, driven by unprecedented demand for Ozempic and Wegovy. Novo Nordisk and Eli Lilly have struggled to meet UK supply, affecting both diabetes patients and those prescribed these drugs for weight management.
Current Active Shortages (0)
✅ No active shortages currently match these medications. Sign up below to get alerted if this changes.
What to Do If Affected
- Contact your prescribing clinic immediately if supply is disrupted
- Do NOT buy GLP-1 medications from unregulated online sources
- Ask your GP about alternative weight management medications
- Diabetes patients on GLP-1s take priority over weight-loss patients — speak to your GP
- Report suspected counterfeit medications to MHRA Yellow Card
If you need it today
Related Medicine Pages
Don't get caught off guard
Free email alerts if a medicine you take goes into short supply. Alerts are rare — that's good news.
Search shortages free →
Reviewed for source alignment: 11 August 2026 · Report an accuracy issue
Data sources: DHSC Medicine Supply Notifications · NHSBSA Serious Shortage Protocols · NHS England
MediWatch is not medical advice. Always follow your prescription label and ask a pharmacist, GP, specialist, NHS 111, or emergency services if you are unsure or unwell. Data checked daily.
Data sources: DHSC Medicine Supply Notifications · NHSBSA Serious Shortage Protocols · NHS England
MediWatch is not medical advice. Always follow your prescription label and ask a pharmacist, GP, specialist, NHS 111, or emergency services if you are unsure or unwell. Data checked daily.